2022 International Congress Archives - Page 99 of 153

Nicotine and influences on hyperkinetic movement disorders

J. Qiu, L. Williams, H. Morales-Briceño, D. Olszewska, T. Lynch, V. Fung (Sydney, Australia)
Nigral microvasculature imaging in Parkinson’s disease

S. Sharma, S. Buch, D. Reese, M. Haacke, M. Jog (London, Canada)
NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)
No association between naturally occurring plasma tau autoantibodies and movement disorders

AD. Magalhães, M. Emmenegger, E. de Cecco, M. Carta, K. Frontzek, A. Chincisan, S. Hornemann, A. Aguzzi (Zurich, Switzerland)
No evidence for the impact of SNCA rs356219 on Parkinson’s disease progression

A. Szwedo, T. Stoker, M. Camacho, D. Backström, L. Forsgren, R. Lawson, A. Yarnall, C. Williams-Gray, A. Macleod, C. Counsell, OB. Tysnes, G. Alves, J. Maple-Grødem (Stavanger, Norway)
Nocturnal attacks of abnormal sleep behaviors and abnormal movements induced by insulin: A case report

S. El-Jaafary (Cairo, Egypt)
Nocturnal Polyuria in Parkinson’s Disease

M. Smith, G. Portlock, A. Cullen, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
NODDI- based maps as potential marker for Parkinson’s Disease.

AP. Prabhu, S. Bhardwaj, A. Indoria, M. Gothwal, R. Yadav, PK. Pal, J. Saini (Bengaluru, India)
Non-apoptotic caspase-3 activation mediates early synaptic dysfunction of indirect pathway neurons in the parkinsonian striatum

C. Li, T. Fieblinger, E. Espa, MA. Cenci (Lund, Sweden)
Non-dopaminergic system is related with motor reserve in Parkinson’s disease

J. Youn, JH. Won, M. Kim, SH. Moon, M. Kim, JH. Ahn, YE. Huh, H. Park, JW. Cho (Seoul, Republic of Korea)